[
    {
        "utterance": "Rosa Krajmalnik-Brown: I point to people so so we have an order. I can go next but I think most of you heard from me yesterday so I'll keep it really short. Just tell you that I'm an environmental engineer by training but I have always worked with microbes and how microbes interact with each other and with their environment. And now this is a topic a very important topic for my gut microbiome research. And now I will pass it to Carolina and after you introduce yourself, please pass it to someone else so we know who's speaking if that's okay. ",
        "annotations": {
            "process management": "The speaker is managing the meeting flow by suggesting an order of speaking.",
            "signal expertise": "The speaker is explicitly stating their own expertise related to the task.",
            "encourage participation": "The speaker is inviting others to contribute by introducing themselves and passing the turn to someone else."
        }
    },
    {
        "utterance": "Carolina Tropini: So I'm at the University of British Columbia. My background is in physics, but I'm currently appointed between microbiology and biomedical engineering. And I would say the the spin that we take on the microbiota is to try to understand how the abiotic environment that is in the gut affects the microbiota and this is important because all the diseases that we know that happen in the gut affects the gut environment whether it's the temperature because you have a fever or local changes say that a tumor will have a different temperature than the rest of the environment. So we take a multi scale approach to try to understand from the single cell level to the organismal level how these physical changes affect the microbiota and therefore host health. And I'll pass it on to Dave. ",
        "annotations": {
            "signal expertise": "The speaker explicitly states her own qualifications and background in physics, microbiology, and biomedical engineering.",
            "develop idea": "The speaker elaborates on her group's approach to studying the microbiota, explaining how they try to understand the effects of the abiotic environment in the gut on the microbiota.",
            "process management": "The speaker manages the meeting flow by passing it on to the next speaker, Dave."
        }
    },
    {
        "utterance": "Dave Durgan: I'm Dave Durgan, uh Baylor College of Medicine. Um, I'm interested in cardiovascular outcomes including stroke and hypertension. And uh for the past several years we've been interested in how gut dysbiosis is linked to these cardiovascular centers. Um, primarily been looking at uh gut derived metabolites, how they affect the immune system uh and gut brain axis in terms of uh regulating some of these cardiovascular relevant regions in the brain. ",
        "annotations": {
            "signal expertise": "The speaker explicitly states their own expertise and qualifications related to their research interests.",
            "develop idea": "The speaker is expanding on their research background and interests."
        }
    },
    {
        "utterance": "Dave Durgan: Um and go to Ilian. ",
        "annotations": {
            "process management": "This code applies because Dave Durgan is managing the meeting flow by transitioning the conversation to another participant, Ilian."
        }
    },
    {
        "utterance": "Iliyan Iliev: Hi, uh I'm Julian Iliev and I'm an associate professor in Wild Cornell Medicine. Uh the lab is focused on uh immunology in general with a uh you know, with a side focus that became something very major uh fungal microbiota. And uh I'm here uh because I'm very interested in the gut brain axis where we recently found uh uh pathway that is basically regulating behavior and it's starting from the gut involves immune cells and signals directly to neurons and uh there are few very interesting ideas to pursue in that area. Otherwise the major focus is inflammatory bowel disease, allergies in human diseases and that's where a lot of concepts come from those uh from those diseases directly in the lab on the translation. ",
        "annotations": {
            "signal expertise": "The speaker explicitly states his own expertise and qualifications related to his research.",
            "develop idea": "The speaker expands on his research focus and shares recent findings related to the gut-brain axis."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: which pathway? Which pathway? Just out of interest. ",
        "annotations": {
            "ask question": "The speaker is requesting information or clarification about a prior statement or idea proposed by another group member."
        }
    },
    {
        "utterance": "Iliyan Iliev: So it's uh uh it's 17. So we found this uh uh organism this community of organisms that is actually uh uh kicking off this uh uh very strong production of 17 and that affected social behavior and from there we went to neuroimmunology. I'm actually coming to Duke next week I will have a seminar there on that topic. ",
        "annotations": {
            "develop idea": "The speaker is expanding on a previously mentioned concept by providing more details about their research findings on the pathway, specifically about the community of organisms producing a strong production of 17 and its effects.",
            "signal expertise": "The speaker indirectly signals their expertise by discussing their research and mentioning an upcoming seminar on the topic, indicating their depth of knowledge in the area."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Yeah, good. ",
        "annotations": {
            "Supportive response": "The utterance expresses agreement or a positive sentiment towards Iliyan Iliev's explanation, indicating a supportive response.",
            "Acknowledge contribution": "The utterance also acknowledges Iliyan Iliev's contribution, albeit minimally."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Email me, email me. Okay. ",
        "annotations": {
            "None": "No relevant code directly applies to this utterance in a straightforward manner based on the provided definitions."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Can you pass it to someone else, Ilian? ",
        "annotations": {
            "process management": "The speaker is managing the meeting flow by asking Iliyan to pass it to someone else."
        }
    },
    {
        "utterance": "Iliyan Iliev: Yeah, so uh uh Pamela. ",
        "annotations": {
            "process management": "The speaker is managing the meeting flow by passing the turn to someone else, specifically to Pamela."
        }
    },
    {
        "utterance": "Pamela Chang: Hi. Um, my name is Pam Chang and I'm an assistant professor at Cornell in Ithica, New York. Um, I'm trained as a chemist and an immunologist and our lab develops uh chemical approaches to look at the metabolism of the gut microbiome. So we actually make these small molecule probes to look at enzymatic activity, um, with, you know, from the bacteria in the gut. ",
        "annotations": {
            "signal expertise": "The speaker explicitly states her own expertise and qualifications as a chemist and immunologist and describes her lab's work, fitting the definition of signaling expertise."
        }
    },
    {
        "utterance": "Pamela Chang: Uh pass it to Aida. ",
        "annotations": {
            "process management": "The speaker is managing the meeting flow by passing the turn to another participant, Aida."
        }
    },
    {
        "utterance": "Aida Ebrahimi: Uh, hi everyone. Uh, I'm Aida Ibrahimi. I am at Penn State University. Um, I am an assistant professor in electrical and biomedical engineering. So I think I'm uh kind of like the outsider here. I uh work on developing uh nanobiosensors and micro devices for um monitoring and detecting different uh targets. We have been looking at small molecules like uh neurochemicals and biogenic amines as well as uh whole cell bacteria. Um, for example, we have been looking at the the response of bacteria to antibiotic or antibiotic antibacterial susceptibility testing. Um, it's response to osmotic pressure and osmotic stress in real time using these tools, devices that we make uh and uh we have been working on combining multimodal electrochemical readout with machine learning to use this data fusion to improve the robustness and accuracy of the biosensors that we um develop. So in a nutshell. ",
        "annotations": {
            "signal expertise": "Aida explicitly states her position as an assistant professor in electrical and biomedical engineering, signaling her expertise.",
            "develop idea": "Aida elaborates on her work in developing nanobiosensors and microdevices, including specific areas of focus and methodologies."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Nice. ",
        "annotations": {
            "Supportive response": "Rima is expressing a positive evaluation of Aida's introduction.",
            "Acknowledge contribution": "Rima is verbally recognizing Aida's input, albeit briefly."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Rosa, shall we go to the task to the task? ",
        "annotations": {
            "process management": "The speaker is managing the meeting flow by suggesting a transition to the main task."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: We're missing Jao. We're missing Jao. ",
        "annotations": {
            "process management": "The speaker is noting the absence of a participant, which relates to managing the meeting flow or structure."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Sorry, sorry. ",
        "annotations": {
            "None": "No relevant code applies to this utterance as it is an expression of apology and does not explicitly convey any of the defined behaviors."
        }
    },
    {
        "utterance": "Yanjiao Zhou: Hi everyone. Uh and uh I'm assistant professor from University of Connecticut Health Center and uh my lab folks on um intermittent fasting. So we are we are very heavy on on diet. So we focus on intermittent fasting in multiple sclerosis. Uh we are looking at the uh you know, how fasting change the multiplet in gut microbiome. Uh and uh so yeah, we are very interested in how how you know, uh through diet to control the microbiome. ",
        "annotations": {
            "clarify goal": "The speaker is defining their research focus."
        }
    },
    {
        "utterance": "Yanjiao Zhou: That's what we do. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Nice. ",
        "annotations": {
            "acknowledge contribution": "The speaker verbally recognizes another group member's input.",
            "supportive response": "The speaker expresses a positive evaluation for the group member's contribution."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: All right, so I posted the task on the chat just to keep us, you know, in case anyone doesn't have it close. So I posted it there, but um continue Rima. I I cut you off because I wanted to make sure that. ",
        "annotations": {
            "process management": "The speaker is managing the meeting flow by ensuring everyone has access to the task and allowing Rima to continue speaking.",
            "encourage participation": "The speaker is encouraging Rima to participate by asking her to continue sharing her thoughts."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: I'm good, I'm good. ",
        "annotations": {
            "supportive response": "The speaker is expressing agreement or validation of the previous action."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: work Rosie, we enjoyed tremendously your talk yesterday powerful. right? I I just wanted to make few remarks maybe to get so our task is to look at depression anxiety that's what we are doing yes is microbiome changes could be engineered to be protective. We want to engineer that's the ultimate goal. ",
        "annotations": {
            "supportive response": "The speaker expresses appreciation and positive evaluation for Rosie's talk.",
            "clarify goal": "The speaker defines the task and ultimate goal of engineering microbiome changes to be protective against depression and anxiety."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: And we need a scribe. ",
        "annotations": {
            "process management": "The speaker is managing the meeting flow by identifying a need for a scribe to take notes or record the discussion."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Rosa, Rosa, okay. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: And we need a scribe? Can we get a scribe before we start talking? ",
        "annotations": {
            "process management": "The speaker is managing meeting flow by inquiring about getting a scribe before proceeding with the discussion.",
            "assign task": "The speaker is also indirectly assigning a role (scribe) to a group member, which is a task related to meeting organization."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: We need a scribe. Yes. Yes, we need a scribe. Sorry. ",
        "annotations": {
            "process management": "The speaker is managing the meeting flow by requesting a scribe to document their discussions.",
            "assign task": "The speaker is assigning the task of being a scribe to an unspecified group member."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: I'll ask you Rima. ",
        "annotations": {
            "assign task": "Rosa Krajmalnik-Brown is assigning Rima the task of being the scribe."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: should we get one any volunteers? ",
        "annotations": {
            "ask question": "The speaker is requesting information or action from the group members.",
            "encourage participation": "The speaker is inviting group members to volunteer for a task."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Someone who can take notes into these slides. ",
        "annotations": {
            "process management": "This code applies because Rima kaddurah daouk is managing the meeting flow by requesting someone to take notes.",
            "assign task": "This code applies because Rima kaddurah daouk is assigning the responsibility of note-taking to a group member."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: That's what we did yesterday it worked well. ",
        "annotations": {
            "Supportive response": "The speaker is expressing a positive sentiment towards a past approach, indicating agreement or validation with it.",
            "Process management": "The speaker is referencing a past successful method, potentially suggesting its continuation or repetition."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Should we volunteer someone? ",
        "annotations": {
            "process management": "The speaker is asking about the process of volunteering someone to take notes, which is part of managing the meeting flow.",
            "assign task": "The question implies the potential assignment of a task (note-taking) to someone in the group."
        }
    },
    {
        "utterance": "Dave Durgan: Sure, I can do that. ",
        "annotations": {
            "Supportive response": "The speaker is expressing a positive response to the request by volunteering for the task of taking notes."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Okay, thank you. ",
        "annotations": {
            "acknowledge contribution": "The speaker is acknowledging and expressing gratitude for Dave Durgan's offer to be the scribe.",
            "supportive response": "The utterance expresses gratitude, which is a positive evaluation."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Can you can you go into the the link and just start uh taking notes and then what what I did yesterday Rima is I did a little bit before than 10 minutes so we could all see what is written and we can all make sure that the key points are there. ",
        "annotations": {
            "process management": "The speaker is managing the meeting flow by instructing someone on how to take notes and share them with the group.",
            "assign task": "The speaker is assigning the task of taking notes to a group member."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: I'll let you continue talking after we get Dave settled for for scribing. ",
        "annotations": {
            "process management": "The speaker is managing the meeting flow by indicating that she will let others continue talking after ensuring that Dave is settled as a scribe."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: So I think if we think about you know just few remarks I think just to maybe start the the the discussion a bit right? neuropsychiatric disorders whether it's you know degenerative psychiatric right? in general the brain the brain we believe is affected the brain is placed within within a body and is influenced by the body the the brain is dependent on the body. Therefore defining the biochemical axis, the influences of the liver, the gut microbiome, the things we eat, the exposome. ",
        "annotations": {
            "clarify goal": "The utterance helps clarify the goal of discussing the biochemical axis and its influences.",
            "process management": "The utterance manages the discussion process by suggesting starting a discussion."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: We talk about an interconnected highways really that influence from the diet, the the lifestyle, the exposome to the gut microbiome, the influences of the genome added to all of this gives you at the end the readout. ",
        "annotations": {
            "develop idea": "The speaker is expanding on an existing concept by explaining how diet, lifestyle, exposome, and genome influence the gut microbiome and overall health outcomes."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: The readout is the deck of chemicals that we call the metabolome is the readout of all of these influences combined that defines biochemical processes, signaling events and defines quite a bit of our behavior, our biochemistry and including brain brain health. I think what I see from large initiatives by NIH whether right mental health, there's quite a bit of drive to scale up data. ",
        "annotations": {
            "develop idea": "The speaker is expanding on previous discussions about the relationship between the gut microbiome, biochemical processes, and brain health.",
            "supportive response": "The speaker provides a positive evaluation of the drive to scale up data from large initiatives by NIH.",
            "clarify goal": "The speaker is discussing the goal of understanding the biochemical axis and its influences on brain health."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: start early maybe as early as development. My own observations in scaling up data is that the metabolism data in the blood, the information about metabolites in the blood hugely inform about things that that happen in the brain from cognition to imaging to degeneration, there is a sensing mechanism that goes from the blood to the brain and it is phenomenal, more so informative maybe than CSF. It's amazing how much there is a connectivity, right, that predicts. The bacteria produces the bacteria metabolizes some of what we eat clearly and loudly completes our metabolism and we complete the metabolism of bacteria. ",
        "annotations": {
            "develop idea": "The speaker is expanding on existing ideas by sharing observations on how metabolism data in the blood informs about brain-related issues."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: So if we look at the depth of chemicals in the blood, first of all we only know know a small subset of the big metabolome, if I can measure a thousand things today in a year or two I might be able to measure 10,000, 50,000 and what we know today is that many of them are still unidentified. Yes, we know our biochemistry, we can work with a set of metabolites that fits biochemistry we know something about. We are trying to understand the synergy between bacteria and humans, co metabolism, we are trying to model it and we are trying to understand and connect the dots to the brain. I think I'm going to stop here Rosie maybe you want to give your perspective there and then we open it all yeah. ",
        "annotations": {
            "develop idea": "The speaker is expanding on existing ideas about the metabolome, its current state, and future directions.",
            "identify gap": "The speaker mentions that many metabolites are still unidentified, indicating a gap in current knowledge.",
            "clarify goal": "The speaker clarifies the goal of understanding the synergy between bacteria and humans and its connection to the brain."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Yeah, so I agree with everything you said, uh, but I was thinking about the very first question which was the other way around. So we we talk a lot about the gut brain connection, right? But now we have to think maybe and I want to hear from from all of you guys. ",
        "annotations": {
            "develop idea": "She is expanding the discussion by suggesting considering the issue from another angle.",
            "encourage participation": "By inviting others to share their thoughts, she encourages participation."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: What do you think about the other way around? Do these conditions that we're talking about depression and anxiety and the signals that come from the brain affect the gut microbiome and how how do these changes happen? And how do we detect these changes and how do we address these changes? So, um, I have a lot to say but I'm going to try very hard to be quiet because I want to hear from all of you guys so. ",
        "annotations": {
            "ask question": "The speaker is requesting information or thoughts from other team members on the influence of brain signals on the gut microbiome.",
            "encourage participation": "The speaker invites others to contribute their thoughts and opinions."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: And I know that Carolina has her hand up very patiently. ",
        "annotations": {
            "encourage participation": "Rosa Krajmalnik-Brown is encouraging Carolina to contribute by acknowledging that she has her hand up."
        }
    },
    {
        "utterance": "Carolina Tropini: Thanks you know actually um exactly how you said Rosa I I I think that we're missing the other way around. Um there was this paper a couple of years ago about uh uh exercise and how it affects the microbiota through the lactate that is produced by by the muscles and that somehow to me was kind of mind blowing that actually makes it back into the gut and feeds the bacteria. ",
        "annotations": {
            "develop idea": "Carolina is expanding on Rosa's idea about considering the effects of brain conditions on the gut microbiome by providing a specific example.",
            "supportive response": "Carolina is expressing agreement and building on Rosa's statement about the bidirectional interaction between the gut microbiome and brain conditions."
        }
    },
    {
        "utterance": "Carolina Tropini: So thinking about how uh if a person is stressed if a person is producing different types of uh hormones if that makes it back into the gut that's going to be selecting bacteria that that will make different metabolites which then feeds back comes into the entire system. And um and that's just a really hard um loop to figure out and to tease apart cause and effect and but you know I feel like we've in the realm of um what's important on the humans versus microbiome we've we've now become really focused on like the microbiome impacting everything and and I really feel like we're missing a little bit the fact that there's a huge amount that we produce too that feeds back into the microbiota. Uh and um I I think I agree that this is a super important thing to think about because we produce massive amount of things that make it to the microbiome as well. ",
        "annotations": {
            "develop idea": "The speaker is expanding on how human stress and hormones can affect the gut microbiome, suggesting a complex interaction.",
            "identify gap": "The speaker points out a potential gap in understanding, noting that the field may be overly focused on the microbiome's impact on humans, while underconsidering human factors that influence the microbiome."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Good point. ",
        "annotations": {
            "acknowledge contribution": "Rima kaddurah daouk acknowledges Carolina's point.",
            "supportive response": "Rima kaddurah daouk expresses agreement and validation of Carolina's contribution."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Definitely. ",
        "annotations": {
            "Supportive Response": "The speaker is expressing agreement with a previous statement, showing support without adding new content."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Did you get that Dave? ",
        "annotations": {
            "ask question": "The speaker is requesting information or confirmation from Dave regarding whether he received or understood a previous point or piece of information."
        }
    },
    {
        "utterance": "Dave Durgan: Yep. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rima kaddurah daouk: So go ahead Dave. ",
        "annotations": {
            "encourage participation": "This code applies because the speaker is inviting Dave to contribute to the conversation, encouraging him to share his thoughts or input.",
            "supportive response": "This code also applies as the utterance is a supportive and positive response aimed at facilitating Dave's contribution to the discussion."
        }
    },
    {
        "utterance": "Dave Durgan: So I would agree with. ",
        "annotations": {
            "supportive response": "Expressing agreement with a prior statement."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: So. ",
        "annotations": {
            "None": "No relevant code directly applies to this minimal utterance, as it doesn't explicitly perform any of the described actions in a substantial way."
        }
    },
    {
        "utterance": "Dave Durgan: I was just going to just add to that. I think that the top down signaling it's always recognized that it's there but it seems much less well developed. ",
        "annotations": {
            "develop idea": "The speaker is expanding on a previous idea about the brain-gut connection, specifically discussing top-down signaling.",
            "supportive response": "The speaker is agreeing with or building upon previous statements, supporting the idea that there's more to explore in how the brain affects the gut microbiome."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: It's that gut feeling, you know? ",
        "annotations": {
            "express humor": "The speaker uses the idiomatic expression 'gut feeling' which can be interpreted as an attempt to add a touch of humor or informal connection to the discussion."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Yeah, good one, good one. ",
        "annotations": {
            "supportive response": "The utterance expresses agreement and a positive evaluation of a previous statement, which aligns with the definition of a supportive response."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Right, but how do you study it? How can you study it? Really think about it, right? This by directionality which clearly must be there. There must be something going both ways. ",
        "annotations": {
            "ask question": "The speaker is requesting information on how to study the bidirectional interaction between the gut microbiome and other bodily functions.",
            "develop idea": "The speaker is also elaborating on the concept of bidirectional interaction, suggesting that there must be effects going both ways."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: How do we tease it apart? How do we study it? And if we want to end up by fixing the gut microbiome, if it is the other way, if it's coming from the brain and affecting continuously the gut microbiome, are we going to succeed, right? So what are the thoughts? ",
        "annotations": {
            "ask question": "The speaker is explicitly requesting information or clarification on how to study the interaction between the gut microbiome and the brain, and the feasibility of fixing the gut microbiome.",
            "encourage participation": "The speaker invites others to share their thoughts, indicated by 'So what are the thoughts?'"
        }
    },
    {
        "utterance": "Yanjiao Zhou: I I oh okay go ahead sorry. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Yeah, Yanjiao wanted to say something, sorry. ",
        "annotations": {
            "encourage participation": "The speaker is inviting Yanjiao to contribute their thoughts or ideas to the conversation."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: I I I I'm sure I'm I'm messing up your name. So please correct me if I'm saying your name wrong uh Yanjiao. And then say Krajmalnik and then we're good. ",
        "annotations": {
            "ask question": "Rosa Krajmalnik-Brown is seeking confirmation on the pronunciation of Yanjiao's name, which is a direct request for information.",
            "encourage participation": "By asking Yanjiao to correct her if she's pronouncing her name wrong, Rosa is encouraging Yanjiao to participate in the conversation."
        }
    },
    {
        "utterance": "Yanjiao Zhou: It's it's Yanjiao. ",
        "annotations": {
            "None": "The utterance is a simple correction of the speaker's name and does not contain any content that fits into the other categories."
        }
    },
    {
        "utterance": "Yanjiao Zhou: Um you know there's there's still have been um you know the by direction uh regulation had been like a a big issue from the very beginning when we start the microbiome research, right? Because at the beginning people get excited uh you know microbiome associated every disease. ",
        "annotations": {
            "summarize conversation": "The speaker reflects on the history of microbiome research, discussing the challenges and excitement at its beginning.",
            "critical response": "The speaker critiques the initial enthusiasm in microbiome research, where it was associated with many diseases."
        }
    },
    {
        "utterance": "Yanjiao Zhou: And then we ask the question is the microbiome causal uh all that stuff and now we we are entering into another state. So I I guess to answer the question how the how the top down like disease affect uh microbiome, right? ",
        "annotations": {
            "ask question": "The speaker is asking a question about how diseases affect the microbiome, seeking clarification or information.",
            "develop idea": "The speaker is expanding on existing ideas by discussing the progression of research and current questions in the field."
        }
    },
    {
        "utterance": "Yanjiao Zhou: Uh shouldn't we use animal models um because the model if you if you develop this model and you say that whether it's changed the microbiome which we saw in our uh MS models. We know when we immunize the the mice and uh the the you know you got you got MS disease and then the microbiome definitely change. ",
        "annotations": {
            "ask question": "The speaker starts by asking if they should use animal models, seeking input or consideration on this approach.",
            "develop idea": "The speaker elaborates on using animal models, specifically mentioning their experience with MS models and immunizing mice, to study changes in the microbiome."
        }
    },
    {
        "utterance": "Yanjiao Zhou: just a very you know simple idea. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Yeah. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: And I think it's the same with most of the mouse models that the micro is different. ",
        "annotations": {
            "develop idea": "The speaker is expanding on a previous idea about mouse models and their microbiomes.",
            "supportive response": "The speaker is expressing agreement or adding a supportive comment to a previous suggestion about using animal models."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Like if you take an autism mouse model, the microbiome is different, right? So. ",
        "annotations": {
            "develop idea": "The speaker is expanding on an existing idea by providing an example of how certain conditions (autism) affect the microbiome in mouse models.",
            "ask question": "The speaker seeks agreement or clarification with 'right? So,' indicating a question or a call for validation."
        }
    },
    {
        "utterance": "Iliyan Iliev: Yeah but in many ways the direction going, right? Which is which way is the signal going? But but in many situations when you look at that complex composition, it's either non causal or it has an effect that is uh you know, there are a lot of confounders. So we started actually looking at uh uh defining basically partners. ",
        "annotations": {
            "ask question": "The speaker asks about the direction of the signal, which is a clear question.",
            "identify gap": "The speaker mentions the complexity and the issue of confounders, which implies a recognition of gaps in understanding."
        }
    },
    {
        "utterance": "Iliyan Iliev: And then uh defining actually what they're sensing and then knocking out this pathway in the bacteria and uh it can be host metabolite. So then you you if you actually find a sensor then you knock it out and we succeeded in some of those and on plate it works beautifully. In germ free mice it might work but then a lot of those became actually not very interesting because in the complex community they just are not produced enough and there is a pharmacokinetics of each metabolite that we never considered and we started actually changing groups uh in specific metabolite and we have one proof of principle where we did like huge chemical, you know, uh change of the metabolite in different parts of the groups and that changed the pharmacodynamic uh incredibly. ",
        "annotations": {
            "develop idea": "The speaker is expanding on their research approach and findings, discussing how they define what bacteria sense and the effects of knocking out certain pathways.",
            "identify gap": "The speaker identifies a gap in their research by mentioning that they never considered the pharmacokinetics of each metabolite."
        }
    },
    {
        "utterance": "Iliyan Iliev: But it didn't change the lack of activity if it's in a complex community. So a lot of reductionist approaches are teaching us about the pathways but then what is really important in vivo. So uh so so that kind of leaves room for some things to be explored but others become interesting in terms of pathways. ",
        "annotations": {
            "develop idea": "The speaker is expanding on previous discussions about the limitations of reductionist approaches in understanding complex biological systems.",
            "critical response": "The speaker is offering a critique of reductionist approaches in the context of complex communities.",
            "identify gap": "The speaker highlights the limitations of reductionist approaches in complex communities and the importance of understanding what is really important in vivo."
        }
    },
    {
        "utterance": "Iliyan Iliev: But then not really physiologically that interesting. So it's always the balance where you want to focus and I spent literally like four years on chemistry like that and you know and uh uh and there are very few hits compared to what we came up with initially. So it's kind of uh you know, the immune side has been far more productive than the other side because just there is an over over compensation or not enough of a metabolite to actually have biological function. And then if you go and try to actually affect neurons and depends where those neurons are and then you can place actually the receptors and you can go with AVVs so now there is technology really. But some of them are just not making it at all. ",
        "annotations": {
            "develop idea": "The speaker is elaborating on their research experiences, challenges, and thoughts on the balance and focus in their work.",
            "identify gap": "The speaker implicitly identifies gaps or challenges in their research, such as the difficulty in affecting neurons and the imbalance in productivity between different sides of their research."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: So Aida, you're a biosensors person. ",
        "annotations": {
            "Signal expertise": "Rosa Krajmalnik-Brown explicitly states Aida's expertise in biosensors."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Yeah. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Can maybe some biosensors help. ",
        "annotations": {
            "ask question": "The speaker is requesting help or suggestions from the group on using biosensors."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Help us some of these signals or messages. ",
        "annotations": {
            "ask question": "The speaker is explicitly requesting help or suggestions from others, indicating a request for information.",
            "encourage participation": "The speaker is inviting others to contribute their thoughts or ideas, encouraging participation in the discussion."
        }
    },
    {
        "utterance": "Aida Ebrahimi: Um so I'm I'm sorry I had to like you know uh get to my student uh there was urgent thing in the lab. ",
        "annotations": {
            "None": "The utterance is a brief apology and explanation for temporarily leaving the discussion, which doesn't directly fit into any of the other categories."
        }
    },
    {
        "utterance": "Aida Ebrahimi: So uh can you like briefly say what type of signals? ",
        "annotations": {
            "ask question": "The speaker is requesting information or clarification about the type of signals being discussed."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: So we're talking about uh how do we maybe measure detect signals from the brain to the gut. ",
        "annotations": {
            "ask question": "The speaker is requesting information on how to measure or detect signals from the brain to the gut.",
            "identify gap": "The speaker implies a gap in current knowledge or methods for measuring signals from the brain to the gut.",
            "clarify goal": "The speaker is seeking to understand how to study the signals from the brain to the gut, which relates to clarifying the goal of such studies."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: We've been talking about the fact that the communication goes goes from the gut to the brain. ",
        "annotations": {
            "Summarize conversation": "The utterance summarizes a point discussed in the meeting, reflecting on the communication direction between the gut and the brain."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: But what about signals from the brain to the gut that are specific to these disorders? ",
        "annotations": {
            "ask question": "The speaker is requesting information about signals from the brain to the gut that are specific to certain disorders, seeking clarification on this aspect of the gut-brain connection."
        }
    },
    {
        "utterance": "Aida Ebrahimi: Yeah you see the currently the pro ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Aida Ebrahimi: that um they are related to my field like biosensors, electrical or electrochemical sensors, they are like implanted devices um that you know, you can basically only look at brain so you put brain probes uh at the specific locations that you want and then you can pick up some some signals, you know? But currently there is nothing like uh that can go all the way through the whole axis uh it doesn't exist uh with GI track uh it's specifically very challenging actually. Uh brain is easiest honestly. The brain probes they have been in the field for 50 years. So it is not even a new thing at all. ",
        "annotations": {
            "develop idea": "The speaker is explaining an existing concept related to biosensors and their application, particularly in relation to brain studies.",
            "signal expertise": "Aida Ebrahimi is stating her field of expertise and explaining concepts related to biosensors.",
            "identify gap": "The speaker mentions that there is currently no technology that can go all the way through the whole axis (from brain to gut), indicating a gap in current technology."
        }
    },
    {
        "utterance": "Aida Ebrahimi: Uh now people are trying to make the probes and those sensors better, like for example, rather than using uh middle like um uh probes uh that are based on carbon fiber and they are like, you know, very fragile and etcetera, like making like flexible patches uh that you can make array of them uh using novel materials and do the measurement uh with brain and even like, you know, at the um wireless um circuit, so you don't have to like, you know, the the the wires they don't have to like stick out of the brain because that's currently how it is. There is always some wires like sticking out. So how you can implant it and also have the data communication circuit combined with that sensing modality. So there are a lot of progress in that field and that's great for brain. ",
        "annotations": {
            "develop idea": "Aida Ebrahimi is expanding on existing ideas about improving sensor technology for brain measurements, discussing the transition from fragile carbon fiber probes to more advanced flexible patches and wireless circuits.",
            "propose new idea": "Aida introduces new approaches such as using flexible patches and wireless circuits for brain measurements, indicating potential new directions in the field."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Yeah, important Aida. ",
        "annotations": {
            "acknowledge contribution": "verbally recognizes another group member's input",
            "supportive response": "Expressing agreement, validation, or positive evaluation for other group members' contributions"
        }
    },
    {
        "utterance": "Aida Ebrahimi: Yeah. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Sorry, go ahead. Go ahead, continue. ",
        "annotations": {
            "supportive response": "The speaker is expressing agreement and encouragement for the previous or next speaker to continue.",
            "encourage participation": "The speaker is inviting someone to contribute their thoughts or continue speaking."
        }
    },
    {
        "utterance": "Aida Ebrahimi: But with GI track um it hasn't been because of the, you know, it's very complex. There are some works that they have shown that okay, let's make capsules, like a smart capsules, a smart pills that you eat and uh, you know, there are ideas actually, like calls by NIH I remember it had started like last year. Uh it has been, you know, this idea has been around actually for a long time. I remember I was a student and this smart pill thing was mentioned multiple times, but I haven't seen any really advancement and real thing rather than some passive components that they can go through and sample, sample like for example, go to intestine and sample bacteria, then the human or the subject um excrete that and then they collect the sample and do the traditional analysis, you know? But something that for example, can do all this screening, even simplest electrical screening and give the signal out because you see in our body we cannot stick wires out. That's the thing. With brain, that's as at least like to some extent you say it's here, it doesn't move, that's another big problem. It doesn't move, it is fixed. So even if there are some wires coming out, that's still okay. But how are you going to do that with, you know, with the like our stomach or our intestine, you know? Where are the wires are going to come out? ",
        "annotations": {
            "identify gap": "The speaker highlights the challenges and limitations in developing technologies for the GI tract, specifically the difficulty in obtaining signals or placing wires due to its anatomy and movement.",
            "offer feedback": "The speaker provides feedback on current ideas for developing smart pills or capsules for the GI tract, discussing the challenges and limitations, including the lack of advancement beyond passive components."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Where are they going to go? ",
        "annotations": {
            "Ask question": "The speaker is requesting information or clarification on where the wires for biosensors or probes are going to be placed or directed, specifically in the context of the gastrointestinal tract."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: But Aida from from an engineering point of view, uh out of if we put a list of all metabolites that we know are gut bacteria human co metabolism influence. We can put a list. We are after it and it's going to expand. You know, it's expanding by the day. But if we say neurotransmitters from the GABA, and serotonin, glutamate, norepinephrin, out of all of these, what what do we have? We know we can do a FMR. ",
        "annotations": {
            "ask question": "The speaker is requesting information or clarification on what is known about certain neurotransmitters and their study."
        }
    },
    {
        "utterance": "Aida Ebrahimi: For all of them like GABA and you know, the catacolamines, glutamate, for all of them sensors uh exist, electrochemical sensors. ",
        "annotations": {
            "develop idea": "The speaker is expanding on the capabilities of sensors for detecting neurotransmitters like GABA, catecholamines, and glutamate, providing specific information about the existence of electrochemical sensors for these substances."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Electrochemistry, yeah. ",
        "annotations": {
            "supportive response": "The speaker is expressing agreement or validation regarding the mention of electrochemistry."
        }
    },
    {
        "utterance": "Aida Ebrahimi: Yes. ",
        "annotations": {
            "supportive response": "Aida Ebrahimi is expressing agreement or confirmation with Rima kaddurah daouk's statement."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Electrochemistry based. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Aida Ebrahimi: Yes. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Aida Ebrahimi: Electrochemical sensors they exist. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Aida Ebrahimi: Um now for an those probes that I mentioned for brain, they actually can do this. Uh they can achieve this detection. ",
        "annotations": {
            "Develop idea": "Aida is elaborating on the capabilities of probes mentioned earlier, providing more details about their functionality.",
            "Supportive response": "Aida is providing a positive affirmation that these probes can achieve the detection mentioned."
        }
    },
    {
        "utterance": "Aida Ebrahimi: Uh now if we want to, so, you know, my point was, let's say someone's someone says, like for example myself, I'm very interested in saliva monitoring, sweat monitoring, uh non-invasive monitoring. So I always have asked like, you know, experts such as yours, such as you, um like are they like the signatures um that I can just look at saliva for those biomarkers and correlate that to Parkinson disease or Alzheimer or things like that. ",
        "annotations": {
            "ask question": "Aida Ebrahimi is seeking information about whether there are signatures or biomarkers in saliva or sweat that can be correlated with diseases like Parkinson's or Alzheimer's, indicating she is asking a question."
        }
    },
    {
        "utterance": "Aida Ebrahimi: Because saliva or sweat, they are really non-invasive and you know, it's easier uh to make sensors for them from my perspective. ",
        "annotations": {
            "supportive response": "The speaker is expressing a positive evaluation for the ease of making sensors for saliva or sweat.",
            "None": "No other code seems to directly apply to this utterance as it does not introduce new ideas, ask questions, signal expertise, identify gaps, or engage in other coded behaviors."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: That's great. ",
        "annotations": {
            "supportive response": "The utterance expresses a positive evaluation of a previous statement, indicating agreement or approval."
        }
    },
    {
        "utterance": "Aida Ebrahimi: But you see the concentrations are so tiny. ",
        "annotations": {
            "identify gap": "The speaker highlights a challenge in detecting biomarkers due to their tiny concentrations, implicitly identifying a gap in current technology or methods.",
            "supportive response": "The speaker contributes to the discussion by acknowledging and emphasizing the difficulty of detecting tiny concentrations of biomarkers."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Brain for all. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Aida Ebrahimi: Yeah. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Aida Ebrahimi: Yeah, yeah. So exactly. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rima kaddurah daouk: For all compounds. ",
        "annotations": {
            "Acknowledge contribution": "Rima kaddurah daouk is acknowledging a point made by Aida Ebrahimi regarding the detection of compounds.",
            "Supportive response": "The utterance expresses agreement or validation with what Aida Ebrahimi discussed about detection capabilities."
        }
    },
    {
        "utterance": "Aida Ebrahimi: Yeah, yeah. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Aida Ebrahimi: So if it. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rima kaddurah daouk: I think that. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Aida you are right on. ",
        "annotations": {
            "Supportive Response": "Rima expresses agreement with Aida's perspective, showing a positive evaluation of her contribution."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: We do not need to get to the brain for everything, right? ",
        "annotations": {
            "supportive response": "The speaker offers an alternative perspective on approaching the study of gut-brain interactions.",
            "ask question": "The utterance ends with a question seeking agreement or confirmation."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: If we believe that neuropsychiatric disorders are systemic diseases and everything we have done over the past 20 years metabolically is telling us, look, the brain is affected, but many other organs are affected. ",
        "annotations": {
            "Develop idea": "The speaker is expanding on the concept of neuropsychiatric disorders being systemic and affecting multiple organs, building upon existing knowledge.",
            "Clarify goal": "The speaker is emphasizing the importance of considering neuropsychiatric disorders from a systemic perspective, affecting not just the brain but other organs as well."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: And this might be a systemic disregulation metabolically, right? Across connecting the compartments, saliva, blood, urine, things we can measure easily is a is a must, is a must, really. ",
        "annotations": {
            "develop idea": "The speaker expands on the idea that neuropsychiatric disorders might be related to systemic metabolic disregulation.",
            "offer feedback": "The speaker suggests considering multiple bodily compartments (saliva, blood, urine) for measurements.",
            "clarify goal": "The speaker clarifies the importance of a systemic approach for understanding neuropsychiatric disorders."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: And I think. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rima kaddurah daouk: That's it. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rima kaddurah daouk: But you. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Iliyan Iliev: Carolina has been raising her hand very patiently. ",
        "annotations": {
            "encourage participation": "The speaker is inviting Carolina to contribute her thoughts or ideas by pointing out she has been raising her hand."
        }
    },
    {
        "utterance": "Iliyan Iliev: Oh, sorry. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Iliyan Iliev: You can also start directing. ",
        "annotations": {
            "process management": "The speaker is suggesting a way to proceed with the discussion or meeting, which aligns with managing the meeting flow."
        }
    },
    {
        "utterance": "Carolina Tropini: I mean maybe it's a little bit easier. ",
        "annotations": {
            "supportive response": "Carolina is expressing a brief agreement or acknowledgment, which can be considered a supportive response."
        }
    },
    {
        "utterance": "Carolina Tropini: Um. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Carolina Tropini: I guess one thing that I was going to say is that. ",
        "annotations": {
            "process management": "The speaker is managing the conversation flow by prefacing their contribution to the discussion."
        }
    },
    {
        "utterance": "Carolina Tropini: I think we also need to think about sensors that are more localized instead of just like saying like taking from the saliva or from the stool. ",
        "annotations": {
            "offer feedback": "Providing a suggestion for using more localized sensors instead of general approaches like taking samples from saliva or stool.",
            "develop idea": "Building upon the idea of using sensors or biosensors by specifying the need for localized sensors."
        }
    },
    {
        "utterance": "Carolina Tropini: Because at least for the microbiota the concentrations can be really, really high but locally. So if you if you measure them out of the entire stool and the entire saliva, you might see that they're very low levels, but in practice they're they can if they're locally at a really high level, they can have physiological effects that are really high. ",
        "annotations": {
            "develop idea": "Carolina is expanding on the idea that local concentrations of microbiota can have significant physiological effects, building upon previous discussions.",
            "identify gap": "Carolina identifies a gap in current measurement methods, suggesting that measuring localized concentrations is more informative than measuring from entire samples."
        }
    },
    {
        "utterance": "Carolina Tropini: Yeah. ",
        "annotations": {
            "supportive response": "The utterance 'Carolina Tropini: Yeah.' expresses agreement or validation with a previous statement, making it a supportive response."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Should we move to the next question because we have a limited amount of time? ",
        "annotations": {
            "process management": "The speaker is managing the meeting flow by suggesting a move to the next question due to time constraints."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: This is a great discussion, but maybe we should move to the next question or the next questions. So I just put it in the chat, which is is it possible that the that microbiome changes could be engineered to be protective against negative impact of mental health disorders. ",
        "annotations": {
            "process management": "The speaker is managing the meeting flow by suggesting a move to the next question.",
            "clarify goal": "The speaker is defining a topic for potential discussion, which is engineering microbiome changes to be protective against negative impacts of mental health disorders.",
            "encourage participation": "The speaker is inviting discussion on a specific topic by referencing a question posted in the chat."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: I I can start on that maybe. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Iliyan Iliev: Uh. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Iliyan Iliev: Uh so so I've been looking a lot into it and then we designed our own studies based on that. So the short question uh answer is yes, you can do that in mice. ",
        "annotations": {
            "develop idea": "The speaker is expanding on the discussion by sharing their research findings on engineering microbiome changes in mice.",
            "signal expertise": "The speaker is sharing their research experience, indicating their expertise in the area."
        }
    },
    {
        "utterance": "Iliyan Iliev: Uh and uh it works for certain types of behaviors and uh we have done it with fungal community but there are a lot a lot of studies done it with bacterial communities with specific metabolites, but the problem is when you move to people because uh because actually the the way and the timing of uh behavior that is learned and then can lead to actually a depressive disorder or something like that. ",
        "annotations": {
            "develop idea": "The speaker is expanding on an existing idea by providing more details about their research and findings related to microbiome and its impact on behavior and depressive disorders.",
            "identify gap": "The speaker highlights a challenge in their research, which is the transition from findings in mice or controlled environments to humans, indicating a gap in current knowledge or methodology."
        }
    },
    {
        "utterance": "Iliyan Iliev: And then there there there is also a component that is uh you know, because of genetics. ",
        "annotations": {
            "develop idea": "Iliyan Iliev is expanding the discussion by adding genetics as another component that influences the relationship between the gut microbiome and mental health disorders."
        }
    },
    {
        "utterance": "Iliyan Iliev: But Carolina has been raising her hand very patiently. ",
        "annotations": {
            "acknowledge contribution": "The speaker acknowledges Carolina's attempt to contribute to the discussion by raising her hand."
        }
    },
    {
        "utterance": "Carolina Tropini: Oh, sorry. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Carolina Tropini: You can also start directing. ",
        "annotations": {
            "encourage participation": "Carolina is inviting Iliyan Iliev to contribute to the discussion, encouraging participation."
        }
    },
    {
        "utterance": "Carolina Tropini: I mean maybe it's a little bit easier. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Carolina Tropini: Um. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Carolina Tropini: I guess one thing that I was going to say is that I think we also need to think about sensors that are more localized instead of just like saying like taking from the saliva or from the stool because at least for the microbiota the concentrations can be really, really high but locally. So if you if you measure them out of the entire stool and the entire saliva, you might see that they're very low levels, but in practice they're they can if they're locally at a really high level, they can have physiological effects that are really high. ",
        "annotations": {
            "propose new idea": "Carolina proposes using more localized sensors instead of measuring from saliva or stool.",
            "develop idea": "She expands on the idea by explaining the limitations of current methods and the potential benefits of localized measurements."
        }
    },
    {
        "utterance": "Carolina Tropini: Yeah. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Should we move to the next question? ",
        "annotations": {
            "process management": "The speaker is managing the meeting flow by suggesting a transition to the next question."
        }
    },
    {
        "utterance": "Iliyan Iliev: It's very confounding though. ",
        "annotations": {
            "critical response": "The speaker expresses a concern about the complexity of the bidirectional relationship between the gut microbiome and mental health disorders, indicating that it is confounding."
        }
    },
    {
        "utterance": "Iliyan Iliev: That that's the problem, right? ",
        "annotations": {
            "supportive response": "The speaker is expressing agreement and acknowledgment of a problem, seeking shared understanding."
        }
    },
    {
        "utterance": "Iliyan Iliev: you know or make drugs that are hitting that pathways where the key should be I think in that direction. ",
        "annotations": {
            "propose new idea": "The speaker introduces an alternative approach of using drugs to target specific pathways.",
            "develop idea": "The speaker elaborates on this approach by specifying that the drugs should target pathways where the key to solving the problem lies."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: I want to give one example, are you familiar with the work of Michael Fishback at Stanford? Yeah. Yeah, nice beautiful work. So I give you one example, right? We see that the indoors, let's stay with the indoors, call the bile acid, the indoors, sulfate is produced by gut bacteria out of metabolism, yes, and you can have an over producer or an under producer of sulfate. We know now high levels is no good. We know it's in the brain. We know there is no synthetic route for it in the brain. ",
        "annotations": {
            "ask question": "The speaker asks if others are familiar with Michael Fishback's work at Stanford.",
            "develop idea": "The speaker then shares and elaborates on an example related to gut bacteria and sulfate production."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Nothing that we can pick in as you know and so on. It must be coming most likely from from the gut. the the gut might have changed either because the brain send the signal or the diet send the signal, something changed, yeah? End result the gut microbiome changed, I am an over producer of this compound that is not good for anxiety. Yes? Okay, so can I change all together the gut microbiome composition genetically, chemically is part of what Michael Fishback does. So he can engineer now a whole area of a new gut microbiome knocking down specific enzymes that produce sulfate. ",
        "annotations": {
            "develop idea": "The speaker is expanding on the concept of engineering the gut microbiome to protect against mental health disorders, discussing genetic and chemical methods.",
            "ask question": "The speaker poses questions about changing the gut microbiome composition, inviting discussion or sharing knowledge."
        }
    },
    {
        "utterance": "Iliyan Iliev: Yeah, because we modulate completely. That's what we do as well and the behavior changes but in humans I mean my colleague here comes from that lab and I'm very very well yeah. ",
        "annotations": {
            "signal expertise": "The speaker mentions familiarity with the work being discussed, indicating expertise.",
            "develop idea": "The speaker is building upon existing ideas or contexts provided by previous speakers."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: of course. ",
        "annotations": {
            "acknowledge contribution": "The utterance 'of course' is an acknowledgment of Iliyan Iliev's statement or contribution to the discussion."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: But how do you take that to humans, Rima, which is that's the way forward. ",
        "annotations": {
            "ask question": "Rosa seeks clarification on how to apply findings to humans.",
            "develop idea": "Rosa aims to understand the application of an existing idea (engineering the gut microbiome) in humans."
        }
    },
    {
        "utterance": "Iliyan Iliev: That's the way forward. ",
        "annotations": {
            "supportive response": "The utterance expresses agreement with a previous statement or proposal."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Are we talking about fecal transplant of specific engineered types of gut microbiomes, right? And what what do we need to get there? Is it yeah, are we there? Maybe not. Maybe not yet. Yes? Maybe not yet. ",
        "annotations": {
            "ask question": "The speaker is requesting information and clarification on the approach of fecal transplant of specific engineered types of gut microbiomes.",
            "clarify goal": "The speaker is trying to understand the objectives and current status of this approach."
        }
    },
    {
        "utterance": "Iliyan Iliev: Well but the studies on the fecal transplant, do you like them? I you know, we we do fecal transplant in IBD and I I had to read all the studies on others, the weakest one are in autism. No question. ",
        "annotations": {}
    },
    {
        "utterance": "Iliyan Iliev: The weakest the the weakest FMT if you go to the to to read basically how the study was designed and how the conclusions came, you know, the strongest one are in Cdiff of course, in IBD they are good. then you go to cancer therapy they are good. You go to autism and any other things. ",
        "annotations": {
            "critical response": "The speaker is providing a negative evaluation of the strength of studies in certain areas (like autism) compared to others.",
            "offer feedback": "The speaker is offering a critique of study designs and conclusions in the field of FMT research."
        }
    },
    {
        "utterance": "Iliyan Iliev: And just read the clinical design and outcome and how can you you know like I I read the studies I'm not convinced of the effect. ",
        "annotations": {
            "critical response": "Iliyan Iliev is expressing skepticism about the effectiveness of certain clinical studies, which is a questioning of the validity or effectiveness of ideas or approaches."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Rose you might disagree. Listen. ",
        "annotations": {
            "encourage participation": "The speaker invites Rose to share her opinion or disagreement, encouraging her participation in the discussion."
        }
    },
    {
        "utterance": "Iliyan Iliev: I don't know. I mean I mean I agree. ",
        "annotations": {
            "None": "The utterance does not explicitly fit into any of the provided codes as it is an expression of uncertainty or agreement without further context."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: I I agree that we need um a a blinded, you know, like a placebo control trial. ",
        "annotations": {
            "supportive response": "Rosa expresses agreement with the suggestion for a blinded, placebo control trial, showing support for the idea."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Yeah. If we agree with that, which you know, or study got reviewed in nature but it didn't get it didn't get um published in nature because the reviewers their main concern was that we didn't have a blinded placebo arm. ",
        "annotations": {
            "critical response": "The speaker is indirectly critiquing the study's design by mentioning the reviewers' concern about the lack of a blinded placebo arm.",
            "clarify goal": "The speaker is discussing the importance of study design, specifically a blinded placebo arm, in achieving research goals."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: But we saw the effects. We totally saw the effects and as we're thinking about the the gut brain and the brain gut communication, I'm thinking maybe these kids once you they didn't have these GI symptoms, they were calmer and that created some different health also the brain to the gut because the gut microbiome changed, changed dramatically after the after the treatment. ",
        "annotations": {
            "develop idea": "The speaker is expanding on previous ideas about gut-brain communication and its implications.",
            "supportive response": "The speaker is expressing a positive view of the observed effects.",
            "clarify goal": "The speaker touches on the goal of understanding how microbiome changes could be protective against negative impacts on mental health."
        }
    },
    {
        "utterance": "Iliyan Iliev: So so that's where probably the that's the area where you know like if clinical studies designed the way the Cdiff study was designed, that's where that can improve a lot. So it's not a critique but it's like actually where things can improve improve, right? In in that kind of uh studies where actually it will become a standard uh as the Cdiff, right? We are learning in IBD a lot from that. ",
        "annotations": {
            "develop idea": "The speaker is expanding on how clinical studies can be improved by being designed like the Cdiff study.",
            "signal expertise": "The speaker references specific studies (Cdiff) and disease areas (IBD), indicating their expertise in the field.",
            "offer feedback": "The speaker is providing constructive feedback on how to improve clinical study designs."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: It's very different by the way because with Cdiff you do one inoculation and it's with one inoculation and in autism it doesn't work that way. You have to do. ",
        "annotations": {
            "develop idea": "The speaker is elaborating on the differences in treatment approaches for Cdiff and autism, building upon previously discussed ideas about microbiome and mental health."
        }
    },
    {
        "utterance": "Iliyan Iliev: Yeah. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rima kaddurah daouk: get better over time and NIH is hosting a workshop on precision probiotics prebiotics they are hosting a big debate. Yes? I mean similar to how we are personalizing medicine, we want to be able to personalize right probiotics prebiotic one. So I think it's it's a matter of time but we will get better. We should not give up. Yes? We know the results are not giving up for sure. ",
        "annotations": {
            "develop idea": "The speaker is building upon the idea of improving gut microbiome studies and treatments, specifically mentioning precision probiotics and prebiotics.",
            "identify gap": "The speaker implies that there is a gap in current research and treatment, specifically in personalizing probiotics and prebiotics.",
            "supportive response": "The speaker encourages persistence ('We should not give up.') and expresses optimism about future improvements."
        }
    },
    {
        "utterance": "Yanjiao Zhou: especially for this group of people. Um but you know the other question I'm always ask myself it's you know we are all microbiome person you know we we we definitely do this research but really I think the key question is to what extent the microbiome is important to the disease. Because the disease is just so complicated and microbiome may play a role but if if the role it's it's you know big enough to have impact. ",
        "annotations": {
            "ask question": "The speaker is requesting information or clarification on the extent of the microbiome's importance in disease.",
            "identify gap": "The speaker recognizes that the disease is complicated and there is uncertainty about the significance of the microbiome's role."
        }
    },
    {
        "utterance": "Iliyan Iliev: Yeah, the the fecal transplant studies they are probably the key but uh how to design them and especially early life. So Rosie like the that that's where the opportunity is but uh you know how to design them in a way to really uh have a big study when you have to and and like kids it's even better, right? Because it's actually not uh is the most challenging group to design a clinical trial. That's why they are less developed but uh that's probably where we can learn a lot. ",
        "annotations": {
            "develop idea": "The speaker is discussing and elaborating on the concept of fecal transplant studies, their potential, and the challenges of designing studies.",
            "ask question": "The speaker is inquiring about how to design studies, especially in early life or with children.",
            "identify gap": "The speaker highlights the gap in knowledge on designing effective clinical trials, particularly with children."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: I do have to say it's quite challenging. You know, there are like the presentation that I gave yesterday is 10 years of research and it is really, really quite, you know, challenging. ",
        "annotations": {
            "signal expertise": "The speaker mentions a presentation from 10 years of research, indicating her expertise."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: None ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: At one of my um iterations where we were trying to design something that I think would have been amazing if we had done it, uh but it's obviously challenging too. I had a conversation with Emeran Mayer. You probably have known Emeran um about uh scanning the brains of these children before and after the FMT. ",
        "annotations": {
            "develop idea": "The speaker is elaborating on a past attempt to design something, providing context and details about the challenges faced.",
            "identify gap": "The speaker mentions that what they were trying to do was 'obviously challenging too', indicating a recognized gap or difficulty."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: We actually submitted a proposal together, but of course the logistics would have been crazy. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Especially because we're not even in the same state, but I I think that would be amazing if we. ",
        "annotations": {
            "supportive response": "Rosa expresses a positive sentiment towards a previously discussed idea, indicating agreement or enthusiasm."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Amazing, amazing. Rose Rosie and a great guy, Emeran, what a great guy. ",
        "annotations": {
            "supportive response": "The utterance expresses a positive sentiment towards Emeran Mayer, indicating admiration."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: An amazing study, it should be funded. I. ",
        "annotations": {
            "supportive response": "The speaker is expressing a positive evaluation and agreement with the study idea, indicating support without adding new content."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Yeah, that's that's another story, right? ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Another story. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: That's another story, but um my point is that we've been thinking about it and we've been thinking about how to be more systematic, more mechanistic and how can we learn more from what we're doing. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Iliyan Iliev: But but now with the first trial that uh it was probably the most challenging thing to do. The second probably people will be more open. ",
        "annotations": {
            "None": "No relevant code directly applies to this utterance, as it primarily serves as a commentary on the trial process rather than engaging with the specific topics of idea generation, questioning, or direct management of the discussion."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: The second happened during COVID, so that was a bigger challenge, you know. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rima kaddurah daouk: None ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Maybe the next one, but you know. ",
        "annotations": {
            "None": "No relevant code directly applies to this utterance as it seems to be a speculative remark or expression of uncertainty."
        }
    },
    {
        "utterance": "Dave Durgan- Baylor College of Medicine: So also what I'm hearing in terms of examples of probiotics or FMT are more GI related outcomes. Um since we're kind of talking about mental health is are there really many clinical readouts um in terms of effects on brain with probiotics or with FMT. ",
        "annotations": {
            "ask question": "The speaker is requesting information about the existence of clinical readouts related to the effects on the brain with probiotics or with FMT, indicating an inquiry for more information."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: So Emeran Mayer actually uh published many years ago, I'm going to say maybe 10 years ago a study with a probiotic where he showed less anxiety in females that actually took the probiotic and he showed that certain regions in the brain were lighting up differently on on the woman that took the probiotic. ",
        "annotations": {
            "develop idea": "The speaker is expanding on the idea of how probiotics can affect anxiety by referencing a specific study.",
            "acknowledge contribution": "The speaker is acknowledging another researcher's contribution by mentioning their study.",
            "supportive response": "The speaker is providing a supportive example to the discussion about engineering microbiome changes to be protective against mental health disorders."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Important. And can Rosie can can changes in the gut in the in in in the gut reflect and end up being part of the end points in in in in psychiatric neuropsychiatric. ",
        "annotations": {
            "ask question": "The speaker is requesting information or clarification on whether changes in the gut can be part of the endpoints in psychiatric neuropsychiatric conditions."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: I don't I don't think we're there, but I've been thinking a lot about this Rima. This is a great question. ",
        "annotations": {
            "supportive response": "The speaker expresses a positive sentiment towards Rima's question, indicating appreciation and engagement with the topic."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: In whom? ",
        "annotations": {
            "ask question": "The speaker is seeking clarification or specification regarding who is being referred to in the discussion."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: So the gut microbiome might be a sensor, might be a signal, might be something that we could be measuring and using as a biomarker of something else. And it might not this doesn't mean that it's causative. ",
        "annotations": {
            "develop idea": "The speaker is expanding on existing ideas through reasoning about the potential roles of the gut microbiome.",
            "clarify goal": "The speaker is defining what needs to be accomplished by understanding the gut microbiome's role, specifically in relation to its potential as a sensor, signal, or biomarker."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: It just means that something else is changing that is giving you a signal on the gut microbiome. ",
        "annotations": {
            "develop idea": "The utterance expands on the idea that the gut microbiome might be a sensor or signal for changes related to mental health, suggesting that it could be giving a signal about something else changing.",
            "clarify goal": "The utterance discusses the potential role of the gut microbiome in relation to mental health disorders, which relates to defining objectives."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Exactly, exactly. ",
        "annotations": {
            "supportive response": "The speaker is expressing agreement or validation with a previous statement."
        }
    },
    {
        "utterance": "Yanjiao Zhou: Rosa, I have a question for you uh for your clinical study. Under the donor samples, where did you get the donor? Are the cases received the same donor or different donors? ",
        "annotations": {
            "ask question": "Yanjiao Zhou is requesting specific information about Rosa's clinical study, asking where the donor samples came from and if the cases received the same or different donors."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: That is that is a great question and I probably went too fast yesterday and I should have mentioned that, but I had certain amount of time. So each patient actually received microbio from two different donors because the high dose was from one donor and the maintenance dose was from another donor. And we didn't want it that way when we designed it, we wanted just one donor to keep things more systematic, but I would say we got lucky because I think the fact that we added two donors increased the diversity and our maintenance donor actually happened to be a donor that had very high diversity if you looked on the graphs. ",
        "annotations": {
            "develop idea": "The speaker is expanding on a previous point about their study, providing more details about the study's design and outcomes.",
            "offer feedback": "The speaker is sharing insights from their experience, which could be useful for others planning similar studies."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: None ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Iliyan Iliev: Yeah, but that's where the opportunity is. Yeah, after reviewing all the studies, you know, your study and there is one smaller scale and that's about it. It's like the, you know, the field where there is the less human data, that's where the opportunity is. ",
        "annotations": {
            "identify gap": "The speaker explicitly identifies a lack of human data in the field as a gap, which presents an opportunity for research."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Well, there was a study published I think this or last week from China that is one patient, one adult patient. ",
        "annotations": {
            "code name": "develop idea",
            "explanation": "The speaker is expanding the conversation by mentioning another study, which can be seen as building upon the existing discussion about research in the field."
        }
    },
    {
        "utterance": "Iliyan Iliev: Yeah, I mean. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Iliyan Iliev: The other was also like a couple of patients. I reviewed them and I was like uh when I was uh designing our study. I read all those papers. I'm like there is so few. So it's uh. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: It it takes a lot of time, it takes a lot of effort, it takes a huge team. Uh but you know if you can do it, it's worth it. That's what I. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Seriously, right. Rosie, has anyone come back to medical records of people with neuropsychiatric diseases and study systematically how many how many do we see end up with the uh changes of symptoms. ",
        "annotations": {
            "ask question": "The speaker is requesting information on whether there have been studies that review medical records of people with neuropsychiatric diseases to assess changes in symptoms."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: None ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Depression, anxiety, whatever. Uh is there uh does it inform uh using big data including medical records early on. ",
        "annotations": {
            "ask question": "The speaker is requesting information on whether using big data including medical records can inform research or treatment early on.",
            "clarify goal": "The question also implies a seeking of clarity on how or if big data can be used in the context of studying or treating depression and anxiety."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: I don't know, but GI symptoms is also big signal for many of these the neurodegenerative diseases. You know that for Parkinson's like GI symptoms come years before. ",
        "annotations": {
            "develop idea": "The speaker is expanding on the idea that GI symptoms could be an early indicator of neurodegenerative diseases, relating it to previous discussions on the gut-brain axis.",
            "clarify goal": "The speaker is contributing to defining the scope of their investigation by highlighting the importance of GI symptoms in neurodegenerative diseases."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Exactly. ",
        "annotations": {
            "supportive response": "The speaker is expressing agreement with a previous statement, indicating a supportive response."
        }
    },
    {
        "utterance": "Yanjiao Zhou: Rosa, I have a question for your uh for your clinical study. Under the donor samples, where did you get the donor? ",
        "annotations": {
            "ask question": "The speaker is requesting information or clarification about a specific aspect of a clinical study."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: That is that is a great question and I probably went too fast yesterday and I should have mentioned that, but I had certain amount of time. So each patient actually received microbio from two different donors because the high dose was from one donor and the maintenance dose was from another donor. And we didn't want it that way when we designed it, we wanted just one donor to keep things more systematic, but I would say we got lucky because I think the fact that we added two donors increased the diversity and our maintenance donor actually happened to be a donor that had very high diversity if you looked on the graphs. ",
        "annotations": {
            "develop idea": "Rosa is elaborating on the study's methodology and its implications by providing detailed information about the use of two different donors for the FMT."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: None ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Iliyan Iliev: Yeah, and later it came in. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Sorry, just how are we doing on time? ",
        "annotations": {
            "process management": "The speaker is asking about the current time status of the meeting to ensure they are on track."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: So I think we have 18 minutes, 18 minutes, so we can discuss maybe another three or four minutes and then look at the slides, so we can make sure that we're collect good points. What do you think Dave? ",
        "annotations": {
            "process management": "The speaker is managing the meeting flow by suggesting a plan for the remaining time.",
            "ask question": "The speaker is seeking Dave's opinion on the proposed plan."
        }
    },
    {
        "utterance": "Dave Durgan- Baylor College of Medicine: Yeah, that's fine. ",
        "annotations": {
            "supportive response": "Dave is expressing agreement with the proposed plan regarding the discussion time."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Good. ",
        "annotations": {
            "supportive response": "The speaker is expressing agreement or validation to a prior statement."
        }
    },
    {
        "utterance": "Yanjiao Zhou: interesting develop this microbiome based early markers, early microbiome change markers for the disease, correct? ",
        "annotations": {
            "ask question": "The speaker is seeking confirmation or agreement with a question.",
            "develop idea": "The speaker is building upon the existing concept of microbiome research and its application in disease detection.",
            "clarify goal": "The speaker is exploring or seeking to understand the objective of developing microbiome-based early markers."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Yeah, we think that those might help intervention, right? If we have an early marker. ",
        "annotations": {
            "supportive response": "The speaker is expressing agreement and support for the idea that early markers could help with intervention.",
            "clarify goal": "The utterance implies and supports the goal of using early markers for intervention in mental health disorders."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: It doesn't have to be microbiome, but we propose that microbiome could be a signal, maybe. ",
        "annotations": {
            "develop idea": "The speaker is expanding on existing ideas about the microbiome's role in mental health by suggesting it could be a signal."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: I'm just throwing it a thought, you guys can. ",
        "annotations": {
            "encourage participation": "The speaker is inviting others to consider and discuss an idea.",
            "propose new idea": "The speaker is tentatively suggesting an idea for the group's consideration."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Early is everything, early is everything, because we are changing the the paradigm from precision medicine to precision health. We want to preserve health, right? Far easier than treating a disease later. ",
        "annotations": {
            "clarify goal": "The speaker is defining and clarifying objectives related to health and disease prevention.",
            "supportive response": "The speaker is expressing a positive view on the concept of precision health and early intervention."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Yeah. ",
        "annotations": {
            "None": "The utterance 'Yeah' is a brief acknowledgment without adding new content or explicitly fitting into any other category."
        }
    },
    {
        "utterance": "Yanjiao Zhou: I'm just thinking about the gut microbiome. Did we think about other like microbiome, oral microbiome, other parts for the gut brain interactions or for the brain interactions. ",
        "annotations": {
            "ask question": "The speaker is asking for information or clarification on whether other microbiomes, such as the oral microbiome, have been considered for gut-brain interactions or brain interactions."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: I would add it. I would add it as a point. Look look at the compartments. Where are the best sensors? Back to the issue of the sensors, right? Um do we need to interrogate a bit more and connect the dots between the the blood the the saliva and then ultimately the urine as an output, right? Should these be investigated a bit more and connected to gut microbiome composition and connect the dots with the influences of the genome and the and the the the diet and the exposome. Basic information, right? Either it might be easier for you to develop a sensor you put in the saliva, right? Or you in the urine. ",
        "annotations": {
            "identify gap": "The speaker recognizes a gap in knowledge regarding the best sensors and how to connect them to gut microbiome composition.",
            "ask question": "The speaker asks questions about investigating further and the placement of sensors.",
            "propose new idea": "The speaker proposes exploring different bodily compartments for sensor development."
        }
    },
    {
        "utterance": "Aida Ebrahimi (Penn State; she/her): I mean liquid liquid samples are way easier compared to. ",
        "annotations": {
            "supportive response": "The speaker is expressing agreement or validation with a previous statement, indicating that liquid samples are indeed easier to work with."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Of course. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Aida Ebrahimi (Penn State; she/her): compared to fecal samples. So there could be biomarkers that the experts can say, hey, actually, I don't know, this medium, it can be a good um, you know, place to look at, not just fecal sample, you know. ",
        "annotations": {
            "propose new idea": "The speaker suggests exploring other mediums for biomarkers, introducing a new approach.",
            "develop idea": "The utterance builds upon the previous discussion about biomarkers and sample types."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Exactly, I wish we we we are not there yet. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Aida Ebrahimi (Penn State; she/her): Really. ",
        "annotations": {
            "None": "No relevant code applies to this utterance as it is a minimal response."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Yeah, but I but we know there's a lot of information in the blood, in the urine that tells me something about gut microbiome, clearly, yes. ",
        "annotations": {
            "develop idea": "The speaker is expanding on the idea that the gut microbiome's influence can be observed through other means such as blood and urine tests.",
            "offer feedback": "The speaker provides a perspective on how to approach understanding the gut microbiome, suggesting that looking at blood and urine can be informative."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: So either your electrochemistry is exquisite. ",
        "annotations": {
            "Critical response": "The speaker's comment implies a challenge or a high bar for electrochemistry to be effective."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: All of the early studies we did with the depression, anxiety, mood CNS was done with electrochemistry. It is phenomenal. Nothing compares with the exquisitive the sensitivity and the the coverage and the the depth the the of what it covers. ",
        "annotations": {
            "signal expertise": "The speaker is explicitly stating their experience and positive view of electrochemistry.",
            "acknowledge contribution": "The speaker acknowledges the contribution of electrochemistry in their studies.",
            "supportive response": "The speaker is expressing a positive evaluation of electrochemistry."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: It's a huge valuable tool. ",
        "annotations": {
            "Supportive Response": "The speaker is expressing a positive evaluation of something being a 'huge valuable tool', which aligns with expressing agreement, validation, or positive evaluation."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Yeah. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Rosie, shall we go back to minutes? ",
        "annotations": {
            "process management": "The speaker is managing the meeting flow by suggesting a return to discussing the minutes."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: We should yeah, should we go should maybe they can share his his screen and we can look at the slide, is that okay? ",
        "annotations": {
            "process management": "The speaker is suggesting a procedural action to share a screen and look at a slide, which relates to managing the meeting flow.",
            "ask question": "The speaker is also asking for confirmation about the proposed action, which is a request for feedback."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: You want to do that? ",
        "annotations": {
            "process management": "Rosa Krajmalnik-Brown is managing the meeting flow by seeking confirmation on the next action."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Let's do that. ",
        "annotations": {
            "supportive response": "The speaker is expressing agreement to proceed with a previously discussed action."
        }
    },
    {
        "utterance": "Dave Durgan- Baylor College of Medicine: Okay, can everybody see that? ",
        "annotations": {
            "process management": "The speaker is checking if everyone can see a shared resource, managing the meeting flow.",
            "clarify goal": "The speaker is also ensuring that the group can proceed with the discussion or presentation by confirming visibility of the shared content."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Yeah. ",
        "annotations": {
            "supportive response": "The utterance expresses agreement or validation without adding new content."
        }
    },
    {
        "utterance": "Dave Durgan- Baylor College of Medicine: All right, so just want to make sure I got everybody's comments well addressed here. ",
        "annotations": {
            "process management": "Dave Durgan is ensuring that all comments made during the discussion are addressed, which is a form of managing the discussion process."
        }
    },
    {
        "utterance": "Dave Durgan- Baylor College of Medicine: Um talked about the metabolome as a readout for not just biome changes, but it's whole body changes and how these can affect the brain. ",
        "annotations": {
            "summarize conversation": "The speaker is summarizing previous discussions about the metabolome as a readout for biome changes and whole-body changes and their effects on the brain."
        }
    },
    {
        "utterance": "Dave Durgan- Baylor College of Medicine: Um mentioned how the plasma uh even though it's not CSF or at the brain can still be an informative readout for how it affects brain. ",
        "annotations": {
            "summarize conversation": "The speaker is summarizing a previous discussion about the role of plasma as a readout for brain health, comparing it to CSF."
        }
    },
    {
        "utterance": "Dave Durgan- Baylor College of Medicine: Um rather than bottom up, we focus a little bit more on top down signaling and how to measure. ",
        "annotations": {
            "None": "No relevant code directly applies to this utterance"
        }
    },
    {
        "utterance": "Dave Durgan- Baylor College of Medicine: Uh talked about how stress and exercise are altering the biota uh which then in turn can feedback to alter brain chemistry. ",
        "annotations": {
            "develop idea": "The speaker is expanding on existing ideas by explaining how stress and exercise affect the biota, which in turn affects brain chemistry."
        }
    },
    {
        "utterance": "Dave Durgan- Baylor College of Medicine: Uh looked at approaches uh to study this, potentially uh Ilian brought up bacterial receivers of top down signaling and then manipulating those pathways. ",
        "annotations": {
            "acknowledge contribution": "The speaker acknowledges Ilian's contribution by mentioning his idea.",
            "develop idea": "The speaker is expanding on or referring to an existing idea mentioned by another group member (Ilian)."
        }
    },
    {
        "utterance": "Dave Durgan- Baylor College of Medicine: Biosensors for uh many of these neuropeptides that we're talking about. Uh seem to be pretty well developed for the brain, but are lacking for gut. ",
        "annotations": {
            "identify gap": "The speaker highlights a lack of biosensors for neuropeptides in the gut, contrasting with their development for the brain.",
            "develop idea": "The speaker is elaborating on the current state of biosensor technology for neuropeptides, comparing brain and gut."
        }
    },
    {
        "utterance": "Dave Durgan- Baylor College of Medicine: Uh we talked a little bit about other sites uh than just gut, um plasma, sweat, saliva for measuring some of these peptides. ",
        "annotations": {
            "summarize conversation": "The speaker is summarizing previous discussions about measuring peptides in various bodily fluids/sites beyond the gut."
        }
    },
    {
        "utterance": "Dave Durgan- Baylor College of Medicine: Uh we moved then onto can the biota be engineered for protective uh effects. Um kind of came to a consensus that pre clinical studies look promising, but uh we're still uh in an infancy of looking at uh clinical studies. ",
        "annotations": {
            "summarize conversation": "The speaker summarizes part of the discussion, specifically about engineering biota for protective effects and the status of preclinical and clinical studies.",
            "process management": "The speaker manages the discussion flow by indicating a transition to a new topic."
        }
    },
    {
        "utterance": "Dave Durgan- Baylor College of Medicine: And then in terms of uh when's the best time to administer some of these targeted therapies. ",
        "annotations": {
            "Ask question": "The speaker is requesting information about the best time to administer targeted therapies.",
            "Process management": "The speaker's question implies a discussion about the methodology or timing of treatment processes."
        }
    },
    {
        "utterance": "Dave Durgan- Baylor College of Medicine: Um again, still kind of need better understanding of how early can you detect these changes in the biome before over symptoms arise. ",
        "annotations": {
            "identify gap": "The speaker explicitly states a need for better understanding of how early changes in the biome can be detected before symptoms arise, indicating a gap in current knowledge.",
            "clarify goal": "The speaker is highlighting the goal of achieving early detection of biome changes to potentially prevent or mitigate symptoms."
        }
    },
    {
        "utterance": "Dave Durgan- Baylor College of Medicine: Uh and this is going to require longitudinal studies. ",
        "annotations": {
            "process management": "The speaker is discussing the necessity of longitudinal studies, which is about managing the research process and study design."
        }
    },
    {
        "utterance": "Dave Durgan- Baylor College of Medicine: And pre clinical wise, there's really only a few studies right now looking at how these manipulations of the gut are actually having effect on brain chemistry. ",
        "annotations": {
            "identify gap": "The speaker is pointing out a gap in research, specifically that there are only a few preclinical studies looking at how gut manipulations affect brain chemistry.",
            "summarize conversation": "The speaker is summarizing the current state of preclinical research regarding the gut-brain axis and microbiome manipulation."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: So uh we also agreed that early intervention would be great if we can find signals that help early intervention. ",
        "annotations": {
            "summarize conversation": "The speaker summarizes a previous agreement about the importance of early intervention.",
            "clarify goal": "The utterance reiterates the goal of finding signals that help early intervention."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: For plasma, I would put blood. It could be plasma serum, anything blood, right? Blood connecting the compartments. if you can change plasma to blood. ",
        "annotations": {
            "develop idea": "Rima kaddurah daouk is elaborating on the concept of using blood or its components (plasma, serum) in studying the gut-brain axis, emphasizing the connection between different biological compartments."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Blood informs about changes in the brain in the first part, yeah. In the first sentence. ",
        "annotations": {
            "develop idea": "The utterance expands on a previous idea by specifying how blood can inform about changes in the brain.",
            "summarize conversation": "The utterance attempts to clarify or summarize a point made earlier."
        }
    },
    {
        "utterance": "Aida Ebrahimi (Penn State; she/her): How about urine? How about urine? ",
        "annotations": {
            "ask question": "The speaker is requesting information or consideration about using urine as a sample for monitoring or detecting signals related to the gut-brain axis or microbiome changes."
        }
    },
    {
        "utterance": "Aida Ebrahimi (Penn State; she/her): Do you think urine is relevant? ",
        "annotations": {
            "ask question": "The speaker is requesting information or clarification on the relevance of urine."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Yeah, important, the urine is important. ",
        "annotations": {
            "supportive response": "The speaker is expressing agreement and validation regarding the importance of urine.",
            "develop idea": "The speaker is building upon a previous idea about urine's relevance."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: I would say, okay, blood right as an okay informative readout informs. I I would just put it as informs about brain changes. Blood blood blood metabolites or blood blood what? Blood markers or blood metabolites, uh blood metabolites inform about brain structural and functional changes or something. ",
        "annotations": {
            "develop idea": "The speaker is expanding on the idea of using blood metabolites as an informative readout for brain changes, discussing how they can inform about brain structural and functional changes.",
            "ask question": "The speaker is seeking input on how to phrase or consider the relationship between blood metabolites and brain changes."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Behavior. I would also add other body fluids. Other body fluids such as saliva and urine could could have added value. ",
        "annotations": {
            "develop idea": "The speaker expands on existing ideas by suggesting specific examples (saliva and urine) of other body fluids that could have added value.",
            "offer feedback": "The speaker provides a specific suggestion for improvement or addition by recommending the inclusion of saliva and urine as body fluids to study."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: So uh Rima, I agree that they inform about brain changes, but it's it's a signal that it's a composite of a lot of other changes too, not just brain changes, right? ",
        "annotations": {
            "develop idea": "The speaker is expanding on an existing idea by providing a nuanced view on how signals from the gut microbiome inform about brain changes.",
            "supportive response": "The utterance expresses agreement with Rima and adds a layer of complexity to the discussion.",
            "offer feedback": "The speaker provides a perspective on considering the composite nature of signals from the gut microbiome."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: So when we take a blood sample, it's metabolism, it's brain, it's microbes, it's everything. ",
        "annotations": {
            "develop idea": "Rosa is expanding on the idea that a blood sample can reflect various aspects of health, including metabolism, brain, and microbes, by highlighting the comprehensive nature of information it contains."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Everything, yeah. ",
        "annotations": {
            "supportive response": "The speaker is expressing agreement and validation for the prior statement about blood samples reflecting various changes."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: It's a composite of like. ",
        "annotations": {
            "develop idea": "The speaker is expanding on the idea that blood samples reflect a wide range of factors, not just brain changes, providing a nuanced view on interpreting blood metabolites as readouts for brain health."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Yes, it is, it is a dump of all organs. ",
        "annotations": {
            "acknowledge contribution": "The speaker verbally recognizes another group member's input."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: But it informs, Rosie, the good news, it informs. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: I agree. ",
        "annotations": {
            "supportive response": "The speaker expresses agreement with a prior statement, showing a positive evaluation."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: About it informs whatever the signal is coming from, it tells me about FDG or neurodegeneration or yeah. ",
        "annotations": {
            "supportive response": "The speaker is expressing agreement and validation regarding the informative value of certain signals for conditions like FDG or neurodegeneration.",
            "develop idea": "The speaker is building upon the previous discussion about biomarkers and their implications for understanding brain changes or neurodegenerative diseases."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: is that the probiotics that we'll be able to purchase at Whole Foods in a few years will be probiotics that came from human guts and that will be more effective because we've proven that those work. ",
        "annotations": {
            "propose new idea": "The utterance introduces a speculative and new idea about the future of probiotics being derived from human guts.",
            "ask question": "The statement is phrased as a question, seeking insight into a potential future scenario regarding probiotics."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: What you guys think? ",
        "annotations": {
            "ask question": "Requesting information or thoughts from other team members",
            "encourage participation": "Inviting others to contribute their expertise, opinions, or ideas"
        }
    },
    {
        "utterance": "Rima kaddurah daouk: clearly yes, you know. ",
        "annotations": {
            "supportive response": "The speaker is expressing agreement or validation with a previous statement or idea."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Hopefully, hopefully we'll get there. Hopefully FDA will allow us to get there soon. ",
        "annotations": {
            "None": "No relevant code directly applies to this utterance as it is a general expression of hope and optimism."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Aida, I the one comment to you, you are in the right field at the right time. Listen, digital medicine, right? Why should we have only a glucose monitor, really, think about it clinically, when you guys can develop an area of sensors that can tell me something about my health in real time. If a glucose monitor can keep me at bay, right? My glucose started to go up immediately. I stopped everything, I did the right diet, exercise, I'm back to normal. I keep my glucose next to me, monitor, imagine how many monitors you can develop, right? Out of the thousands of chemicals that can provide, you are in the right spot at the right time. We we have a big initiative starting on digital and yeah, digital health and ",
        "annotations": {
            "propose new idea": "Rima suggests developing sensors for a wide range of health indicators, similar to glucose monitors.",
            "develop idea": "She expands on the idea by comparing to glucose monitoring and suggesting potential for other health indicators.",
            "supportive response": "Rima is encouraging and supportive of Aida's field and its potential applications."
        }
    },
    {
        "utterance": "Aida Ebrahimi: Yeah. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Richard Wiener: I'll just jump in quickly to say I'm dropping by for the 10 minute warning, but it looks like you guys are summarizing but in any rate. Hi and goodbye. ",
        "annotations": {
            "process management": "The speaker is notifying their presence and the reason for joining late, relating to managing meeting flow and time."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Thank you and goodbye. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Richard Wiener: Bye. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: We were right on time, Rima, before he jumped in. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Yes, thank you. You you managed this beautifully and interesting discussion, beautiful beautiful minds, beautiful amazing scientists of the future who are gonna make amazing things. Wonderful meeting you and working with you, best of luck. ",
        "annotations": {
            "supportive response": "The speaker is expressing agreement and appreciation for the discussion and the participants, providing a positive evaluation of the meeting."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Ilian, welcome to constructive feedback. So I put it on the chat. If you don't mind sending me an email with your constructive um um comments of what you think can be done better. I think. ",
        "annotations": {
            "encourage participation": "The speaker invites Ilian to contribute his thoughts and feedback, encouraging his participation.",
            "process management": "The speaker is managing the meeting process by soliciting feedback to improve the discussion or meeting outcome."
        }
    },
    {
        "utterance": "Iliyan Iliev: Oh sure. I mean, it's actually amazing because it's the first study. So what I thought is like I probably didn't phrase it well, but those studies are the weakest because there is only one. So you have huge opportunity there. That's what I wanted to say. ",
        "annotations": {
            "critical response": "Iliyan Iliev is commenting on the current state of research, pointing out its limitations.",
            "offer feedback": "Iliyan Iliev is suggesting that the limitation of having only one study presents an opportunity for further research."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: And I I added my email as well. Easier than. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Thank you Rima. It was great to come uh doing this with you. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rima kaddurah daouk: The same the same here Rosie, beautiful work, amazing, amazing work, amazing presentation. ",
        "annotations": {
            "supportive response": "The utterance expresses agreement and positive evaluation for Rosa Krajmalnik-Brown's work."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: And um and doing this moderation with you was great like it doesn't always work here with two people. I think it worked great and everyone participated which was great. Thank you all of you too. ",
        "annotations": {
            "supportive response": "The speaker is expressing a positive evaluation of the meeting and thanking participants.",
            "acknowledge contribution": "The speaker is acknowledging the participation and contributions of all the attendees."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Thank you. Thank you Rosie for leading. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: I think we had a great discussion. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rima kaddurah daouk: I think so. ",
        "annotations": {
            "supportive response": "The speaker is expressing agreement with Rosa Krajmalnik-Brown's positive assessment of the discussion."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: I actually personally enjoyed this discussion better than the one I had yesterday. I'm I'm confessing with all of you guys. ",
        "annotations": {
            "Express humor": "The speaker makes a lighthearted comment about enjoying the discussion, which can be considered humorous."
        }
    },
    {
        "utterance": "Carolina Tropini: We won't tell here. ",
        "annotations": {
            "express humor": "The speaker makes a joke about keeping a secret, indicating humor."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Well, I think Dave, Pam and um and Ilian were in my group yesterday. So they might they might feel the same or differently, but I think this was a great discussion. ",
        "annotations": {
            "supportive response": "Rosa expresses a positive evaluation of the discussion, stating she thinks it was great."
        }
    },
    {
        "utterance": "Dave Durgan: Great. ",
        "annotations": {
            "supportive response": "The speaker is expressing agreement or validation for a previous statement or the discussion."
        }
    },
    {
        "utterance": "Rima kaddurah daouk: Thank you. Thank you all. ",
        "annotations": {
            "acknowledge contribution": "verbally recognizes another group member's input, but not agreeing or expanding"
        }
    },
    {
        "utterance": "Aida Ebrahimi: Thank you for being the reporter. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Yanjiao Zhou: It's a lot of work, I know. ",
        "annotations": {
            "acknowledge contribution": "The speaker is acknowledging the effort involved in a task.",
            "supportive response": "The speaker is showing agreement or validation."
        }
    },
    {
        "utterance": "Aida Ebrahimi: Yeah, I did it last year, so I know. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Carolina Tropini: Thank you. Thank you. ",
        "annotations": {
            "acknowledge contribution": "The speaker is verbally recognizing someone's input or contribution to the discussion."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: We're pretty much done, so whenever they call us back, we're good. ",
        "annotations": {
            "process management": "The speaker is indicating the meeting is nearly done and they are ready to be called back, which involves managing the meeting flow."
        }
    },
    {
        "utterance": "Andrew Feig: Uh, yeah, we have about five minutes before some of the other groups are still summarizing. So you're welcome to stay here in the small group and keep talking or we can go back to the main room, whichever. ",
        "annotations": {
            "process management": "The speaker is managing the meeting flow by informing the group about the time and giving them options on what to do next."
        }
    },
    {
        "utterance": "Carolina Tropini: I have a question. Did you take the picture behind you? ",
        "annotations": {
            "ask question": "The speaker is requesting information or clarification about something (the picture behind the person)."
        }
    },
    {
        "utterance": "Andrew Feig: Uh, I did. That was about uh two days ago. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Carolina Tropini: It's beautiful. ",
        "annotations": {
            "supportive response": "The speaker is expressing a positive sentiment about the picture."
        }
    },
    {
        "utterance": "Andrew Feig: Um, that's a great horned owl who uh flew over my head uh maybe two feet of clearance. ",
        "annotations": {
            "express humor": "The speaker makes a joke about a horned owl flying over their head, which is a humorous comment."
        }
    },
    {
        "utterance": "Carolina Tropini: That's crazy. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Andrew Feig: Um, yeah, this is uh out out uh probably about 15 miles from where I live uh near um Saro National Park West. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Carolina Tropini: Were you ready with the camera or do you just like, oh my god, it's coming towards me. ",
        "annotations": {
            "express humor": "The speaker is making a joke or expressing humor about the situation.",
            "ask question": "The speaker is asking a question about Andrew Feig's preparedness or reaction when taking a picture of the horned owl."
        }
    },
    {
        "utterance": "Andrew Feig: No, I was I was ready with the camera. It had been on the branch behind you uh behind me uh uh right before that and so. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Carolina Tropini: Very good. ",
        "annotations": {
            "supportive response": "Carolina Tropini is expressing agreement or validation for a previous statement."
        }
    },
    {
        "utterance": "Andrew Feig: Um, we have we have a lot of great uh birds. The bird the birding in Tucson is phenomenal. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Carolina Tropini: I know. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: So, you know, it's funny that you mentioned birds Andrew because I've been having a hard time sleeping the last week because there's a lot of birds on a tree on a tree right next to my house. Like I I I I got earplugs because they've been waking me up like at 3:00 a.m. the birds. ",
        "annotations": {
            "Express humor": "The speaker makes a joke about their situation with birds waking them up, using it as a humorous anecdote."
        }
    },
    {
        "utterance": "Andrew Feig: You know. And I just told my husband, maybe this will be an advantage of getting hot here. Maybe they'll leave once it gets hot because it's been really bothering my sleep as much as I love birds. We have a problem with the woodpeckers who get a little confused and they go after the some of the aluminum of the uh the drainage off the roof and they go ping ping ping ping ping ping. ",
        "annotations": {
            "express humor": "The speaker is making a joke about the advantage of hot weather possibly making birds leave, and shares a personal anecdote about woodpeckers, indicating humor."
        }
    },
    {
        "utterance": "Carolina Tropini: That's so weird that it happens there too. ",
        "annotations": {
            "supportive response": "Carolina Tropini is expressing agreement and relatability to Andrew Feig's experience, sharing a similar situation."
        }
    },
    {
        "utterance": "Carolina Tropini: Yeah, that it's it's a huge problem right here too. Uh this woodpecker just going crazy on the um on the rain uh collecting um. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Is there another dialog next you know about brain access or that's it because it was two years. ",
        "annotations": {
            "process management": "The speaker is inquiring about the continuation of discussion or if there's another dialogue about brain access, indicating management of the meeting flow."
        }
    },
    {
        "utterance": "Andrew Feig: We run three years. So yes, there. So we have one more we have one more year. Thankfully, hopeful, hopefully in person. In person, exactly. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Andrew Feig: So uh uh so yeah, so we will uh we will have a third year um and then uh you know for for folks that uh who have junior colleagues at the at their institutions obviously, we're running six different dialogs every year on different topics. And so there are opportunities for your colleagues who have different experimental interests to engage. So we have one that overlaps a little bit with this one in that uh the advanced advancing bioimaging or neuroimaging is uh a thread in that. Um, and then we have a new one starting in October on the molecular basis of cognition. Um, uh looking at the pathways that lead to memory formation and memory loss uh trying to get not just to get away from the circuit level which has been well studied, but down to the molecular level of of some of what drives circuit formation etc. So uh ",
        "annotations": {
            "process management": "The speaker is discussing the future plans and organizational aspects of the research dialogs, including the continuation of the program for a third year and the topics to be covered."
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: That's great. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Andrew Feig: Okay, I think we're going to probably need to rejoin the main room. I'm going to send out that message right now, so I'll see you there. ",
        "annotations": {
            "process management": "Andrew Feig is managing the meeting flow by indicating the need to rejoin the main room and informing the group that he will send out a message."
        }
    }
]